RVPH
Reviva Pharmaceuticals Holdings, Inc.
Phase 3
AI-extracted
brilaroxazine
schizophrenia
T-minus 222 days
~ Mar 31, 2027
SEC 8-K
verified 2mo ago
Countdown card →